US Patent 11525130 Process and system for obtaining botulinum neurotoxin
Patent 11525130 was granted and assigned to Allergan, Inc. on December, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11525130 Process and system for obtaining botulinum neurotoxin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
